Evidence map›Paper›PMID 42249514›Full record

ArticleJournal of cannabis research2026

High stakes: how legal cannabis pricing impacts the illicit market.

Rebecca Hebert, Kevin F Boehnke, Spruha Joshi

Abstract read
In one paragraph

Article in Journal of cannabis research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rebecca HebertDepartment of Epidemiology, University of Michigan, Ann Arbor, MI, USA.
Kevin F BoehnkeMichigan Psychedelic Center, University of Michigan, Ann Arbor, MI, USA.
Spruha JoshiDepartment of Epidemiology, University of Michigan, Ann Arbor, MI, USA. spruha@umich.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough nearly 80% of Americans reside in a county with a legal, regulated cannabis dispensary, the majority of cannabis consumed in the U.S. is still obtained from unregulated, illicit sources. Illicit cannabis carries greater health risks and is generally less preferred than regulated cannabis, yet its lower price makes it attractive to many customers. However, comparative research on price differentials between the legal and illicit markets across states is scarce. Establishing cannabis price benchmarks is essential to ensure that legal markets are competitively priced and can effectively displace the illicit trade.

methodsWe used crowdsourced data from PriceofWeed.com to estimate the cost of illicit cannabis in 2018-2024 and data from state government websites to estimate the cost of legal cannabis in Colorado, Oregon, California, Massachusetts, Michigan, Illinois, Maine, and Connecticut. We compared illicit prices by recreational dispensary status in all 50 states and D.C. and examined legal vs. illicit prices within the eight aforementioned recreational states.

resultsThe median price per gram of illicit cannabis was significantly lower in recreational states, compared to non-recreational states ($7.10 vs. $8.90, p < 0.001). While illicit and legal prices were not significantly different over the entire study period, there were significant differences within years and within states. In Colorado, California, and Michigan, legal cannabis was significantly less expensive than illicit cannabis, while in Massachusetts, Illinois, Maine, and Connecticut, illicit cannabis was significantly less expensive than legal cannabis.

conclusionsWe saw lower illicit market prices in states with recreational dispensaries. Our results suggest that the price ranking of legal versus illicit cannabis within a given state differs depending on the state's recreational market maturity, with states with older markets - all of which also had more flexible licensing policies - having a legal cannabis price advantage.

Indexed as

Cannabis policyCannabis pricesIllicit drug marketsRecreational cannabis legalization

Identifiers

PMID42249514
PMCPMC13471419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.